Jun 1, 2016 | Jennifer Dolan Fox, Ph.D.

Exploring Immunotherapies: Beyond Checkpoint Inhibitors

Immunotherapy is an emerging class of cancer treatment, which stimulates the body’s immune system to fight cancer. With the approval of three checkpoint inhibitors (ipilimumab, pembrolizumab and nivolumab) by the FDA in the past five years, immunotherapies are seen as exciting treatments able to elicit durable cures.

Download our white paper to discover:

Let our team support you with identifying new ways to harness the power of the immune system to fight cancer.